Related Experiment Video
Updated: May 5, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Elevated Homocysteine: A Critical Risk Factor for Stroke Types and Subtypes - A Systematic Review and Meta-Analysis
Manyata Srivastava1, Annu Gulia, Pradeep Kumar
1Clinical Research Unit, All India Institute of Medical Sciences, New Delhi, India.
Insights
High homocysteine (Hcy) levels are linked to increased stroke risk. This meta-analysis confirms Hcy as a significant predictor for ischemic and hemorrhagic stroke, highlighting its potential role in stroke prevention strategies.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Biochemistry
Background:
- The link between homocysteine (Hcy) and stroke risk is debated.
- Previous investigations have yielded inconclusive results regarding this association.
Purpose of the Study:
- To systematically review and meta-analyze studies assessing the association between elevated Hcy levels and stroke risk.
- To investigate the relationship for stroke subtypes, including ischemic stroke (IS) and hemorrhagic stroke (HS).
Main Methods:
- A comprehensive literature search was performed across major databases (PubMed, MEDLINE, EMBASE, Cochrane Library) up to April 2024.
- Included case-control studies were analyzed using standardized mean difference (SMD) with 95% confidence intervals (CIs).
- Publication bias and trial sequential analysis (TSA) were conducted to assess the robustness of findings.
Main Results:
- Analysis of 96 studies revealed a significant association between higher Hcy levels and increased risk of IS (SMD = 1.35) and HS (SMD = 1.14).
- Elevated Hcy levels were also significantly linked to Trial of ORG 10172 in Acute Stroke Treatment (TOAST) subtypes of IS (SMD = 1.48).
- Trial sequential analysis confirmed sufficient statistical power for the observed associations across stroke types and subtypes.
Conclusions:
- Elevated homocysteine levels are significantly associated with an increased risk of all stroke types and subtypes.
- Homocysteine shows potential as a predictive biomarker for stroke risk.
- Future research should explore hyperhomocysteinemia detection and Hcy-lowering strategies for stroke prevention.
Background:
The relationship between homocysteine (Hcy) levels and the risk of stroke has been extensively investigated, yet conclusive evidence remains elusive.
Objectives:
This study aims to conduct a systematic review and meta-analysis to determine the association between higher Hcy levels and the risk of stroke, including its types and subtypes.
Materials And Methods:
A comprehensive literature search was conducted in PubMed, MEDLINE, Google Scholar, EMBASE, and the Cochrane Library databases to identify relevant studies published up to April 30, 2024. We included case-control studies that examined the association of Hcy levels with risk of stroke and its types. Pooled standardized mean difference (SMD) with 95% confidence intervals (CIs), publication bias, trial sequential analysis (TSA), and quality assessment was conducted.
Results:
A total of 96 studies were included in the analysis: 83 studies on ischemic stroke (IS), 17 studies on Trial of ORG 10172 in Acute Stroke Treatment (TOAST) subtypes of IS, and 12 studies on hemorrhagic stroke (HS). The meta-analysis revealed a significant association between Hcy levels and risk of IS (SMD = 1.35, 95% CI = 1.14-1.55), TOAST subtypes of IS (SMD = 1.48, 95% CI = 1.03-1.92), and HS (SMD = 1.14, 95% CI = 0.68-1.59). TSA indicated that total sample sizes provided sufficient power (80%) to support findings: IS (n = 33,715), TOAST subtypes of IS (n = 5,655), and HS (n = 4,287).
Conclusions:
High Hcy levels are significantly associated with an increased risk of stroke, including its types and subtypes. These findings underscore the potential of Hcy as predictive marker for stroke risk. Future research should focus on strategies for detecting hyperhomocysteinemia and lowering elevated Hcy levels in high-risk individuals, which may contribute to stroke prevention.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

